Home / Inspections / 1121341

FDA Inspection 1121341 — Seattle Reproductive Medicine, Inc., P.S.

Seattle Reproductive Medicine, Inc., P.S. — FEI 3005033540

The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on February 28, 2020 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Seattle, WA (United States)

Facility

Other inspections at this facility

  • 1275096 (NAI Wed Jul 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019977 (NAI Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910138 (NAI Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810062 (NAI Mon Dec 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 558831 (NAI Wed Jan 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources